SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facility UI Pharmaceuticals is looking forward to supporting the need for larger clinical and commercial lots MimiVax is utilizing SurVaxM in a Randomized Phase 2b clinical trial of glioblastoma BUFFALO, N.Y., Jan….